PPCE Expands Partnership with Medidata
Jan 8, 2018 – Phoenix Progressive Certifications Enterprise Pvt. Ltd. (PPCE), a provider of Clinical Data Management, Biostatistics and Medical Writing services for global pharmaceutical and medical device companies, announced today that it has furthered its partnership with Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research. The Company has accreditations to implement and market Medidata products, including Medidata Coder®, which streamlines and centralizes medical coding.
“In 2016, PPCE made the decision to partner with Medidata to provide our clients with study design and conduct services on Medidata Rave®, the world’s leading solution for capturing, managing and reporting patient data. In October 2017, we completed another accreditation program for the Medical Coding module. Our plan now is to integrate Rave with the Medidata Centralized Statistical Analysis model to further improve the efficiency of the clinical development process by giving our clients the advantage of timely information to aid decision making. Not many companies have access to the sort of meaningful information which can facilitate real-time decisions on, altering the design, for example, or even prematurely terminating a trial if outcomes clearly cannot be achieved.” said Khushnoor Dastoor, executive director & head QA at PPCE.
“We’re thrilled to see the progress PPCE is making with our platform,” said Glen de Vries, Medidata president, and co-founder. “Our partnership highlights how life sciences research can be supported around the world.”
Phoenix Progressive Certifications Enterprise Pvt. Ltd. (PPCE) was founded in 1997 with a vision to add value to the industry by preventing problems arising out of poor quality.
PPCE is a functional service provider of Clinical Data Management, Biostatistics and Medical Writing services for global pharmaceutical and medical device companies. Fully validated platforms and strong quality assurance systems enable PPCE to offer world-class tools for high-quality data resulting in high customer satisfaction and long-term relationships with its partners.
Known for their customized approach designed around clients’ specific requirements, PPCE’s teams have an in-depth knowledge of international regulations and flexible business models to suit different operational requirements. PPCE has experience in Oncology, Urology, Autoimmune Disorders, Respiratory, Cardiovascular and Immunology studies.
Medidata is reinventing global drug and medical device development by creating the industry’s leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including over 950 global pharmaceutical companies, biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 18 of the world’s top 25 global pharmaceutical companies and is used by 18 of the top 25 medical device developers—from study design and planning through execution, management, and reporting.